(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

NCT05236634 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Phosphodiesterase 5 Inhibitors
DRUG: Alpha Blockers
DRUG: Combined Alpha Blockers and Phosphodiesterase 5 Inhibitors

Sponsor

Assiut University